Sengupta N
Janssen Global Market Access, Oncology, Raritan, New Jersey, USA.
Biography
He is affiliated to Janssen Global Market Access, Oncology, Raritan, New Jersey, USA. His Specialties: Global Market Access strategy, Pricing & reimbursement strategy, Value proposition development based on clinical trial, Health economic strategy & input in early & full clinical development (Phase II-IV), L&A assessment, Modeling, Price negotiation, Leading cross-functional global team Led US & Global launch of multiple blockbuster products (IMBRUVICA, XARELTO, HUMIRA) for successful patient access & payor/HTA negotiation worldwide. Expertise in: Rare Disease, Hematology, CGVHD, Solid Tumor, Immunology, CV (drug & device).
